Zdrowie i gospodarka · 11/01/2008

FDA Extends Comment Period for Human Blood and Blood Components Rule

The Food and Drug Administration (FDA) is extending the comment period for a proposed rule regarding human blood and blood components until August 4, 2008, in response to requests for an extension, originally set to end on February 6, 2008.